1.Preface
1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation
2.Executive Summary
2.1.Market Snapshot: Global Carcinoembryonic Antigen Market
3.Market Dynamics
3.1.Introduction
3.1.1. Global Carcinoembryonic Antigen Market Value, 2015-2027, (US$ Mn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition,2020
3.3.1.Source
3.3.2.End-user
3.3.3.Geography
4.Market Positioning of Key Players, 2020
4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players
5.COVID 19 Impact Analysis
5.1.Global Carcinoembryonic Antigen Market Pre Vs Post COVID 19, 2019 – 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply
6.North America
6.1.North America Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
6.2.1.Overview
6.2.2.Colorectal cancer
6.2.3.Pancreatic cancer
6.2.4.Ovarian cancer
6.2.5.Breast cancer
6.2.6.Thyroid cancer
6.2.7.Others
6.3.North America Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
6.3.1.Overview
6.3.2.Hospitals
6.3.3.Laboratories
6.3.4.Others
7.Europe
7.1.Europe Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
7.2.1.Overview
7.2.2.Colorectal cancer
7.2.3.Pancreatic cancer
7.2.4.Ovarian cancer
7.2.5.Breast cancer
7.2.6.Thyroid cancer
7.2.7.Others
7.3.Europe Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
7.3.1.Overview
7.3.2.Hospitals
7.3.3.Laboratories
7.3.4.Others
8.Asia Pacific
8.1.Asia Pacific Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
8.2.1.Overview
8.2.2.Colorectal cancer
8.2.3.Pancreatic cancer
8.2.4.Ovarian cancer
8.2.5.Breast cancer
8.2.6.Thyroid cancer
8.2.7.Others
8.3.Asia Pacific Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
8.3.1.Overview
8.3.2.Hospitals
8.3.3.Laboratories
8.3.4.Others
9.Latin America
9.1.Latin America Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
9.2.1.Overview
9.2.2.Colorectal cancer
9.2.3.Pancreatic cancer
9.2.4.Ovarian cancer
9.2.5.Breast cancer
9.2.6.Thyroid cancer
9.2.7.Others
9.3.Latin America Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
9.3.1.Overview
9.3.2.Hospitals
9.3.3.Laboratories
9.3.4.Others
10.Middle East
10.1.Middle East Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
10.2.1.Overview
10.2.2.Colorectal cancer
10.2.3.Pancreatic cancer
10.2.4.Ovarian cancer
10.2.5.Breast cancer
10.2.6.Thyroid cancer
10.2.7.Others
10.3.Middle East Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
10.3.1.Overview
10.3.2.Hospitals
10.3.3.Laboratories
10.3.4.Others
11.Africa
11.1.Africa Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
11.2.1.Overview
11.2.2.Colorectal cancer
11.2.3.Pancreatic cancer
11.2.4.Ovarian cancer
11.2.5.Breast cancer
11.2.6.Thyroid cancer
11.2.7.Others
11.3.Africa Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
11.3.1.Overview
11.3.2.Hospitals
11.3.3.Laboratories
11.3.4.Others
12.Global
12.1.Global Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
12.1.1.Overview
12.1.2.Colorectal cancer
12.1.3.Pancreatic cancer
12.1.4.Ovarian cancer
12.1.5.Breast cancer
12.1.6.Thyroid cancer
12.1.7.Others
12.2.Global Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
12.2.1.Overview
12.2.2.Hospitals
12.2.3.Laboratories
12.2.4.Others
13.Company Profiles
13.1.F. Hoffmann-La Roche Ltd
13.2.Abbott Diagnostics
13.3.GenWay Biotech Inc.
13.4.Quest Diagnostics
13.5.Creative Diagnostics
13.6.Correlogic Systems, Inc.
13.7.Omega Diagnostics Group PLC
13.8.RayBiotech, Inc.
13.9.Boster Biological Technology
Qiagen N.V.
List of Figures
FIG. 1 Global Carcinoembryonic Antigen Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Carcinoembryonic Antigen Market Segmentation
FIG. 4 Global Carcinoembryonic Antigen Market, by Product, 2019 (US$ Mn)
FIG. 5 Global Carcinoembryonic Antigen Market, by End-user, 2019 (US$ Mn)
FIG. 6 Global Carcinoembryonic Antigen Market, by Geography, 2019 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2019
FIG. 8 Global Market Positioning of Key Carcinoembryonic Antigen Market Manufacturers, 2019
FIG. 9 Global Carcinoembryonic Antigen Market Value Contribution, By Source, 2019 & 2027 (Value %)
FIG. 10 Global Carcinoembryonic Antigen Market, by Colorectal Cancer, Value, 2015-2027 (US$ Mn)
FIG. 11 Global Carcinoembryonic Antigen Market, by Pancreatic Cancer, Value, 2015-2027 (US$ Mn)
FIG. 12 Global Carcinoembryonic Antigen Market, by Ovarian Cancer, Value, 2015-2027 (US$ Mn)
FIG. 13 Global Carcinoembryonic Antigen Market, by Breast Cancer, Value, 2015-2027 (US$ Mn)
FIG. 14 Global Carcinoembryonic Antigen Market, by Thyroid Cancer, Value, 2015-2027 (US$ Mn)
FIG. 15 Global Carcinoembryonic Antigen Market, by Others, Value, 2015-2027 (US$ Mn)
FIG. 16 Global Carcinoembryonic Antigen Market Value Contribution, By End-User, 2019 & 2027 (Value %)
FIG. 17 Global Carcinoembryonic Antigen Market, by Hospitals, Value, 2015-2027 (US$ Mn)
FIG. 18 Global Carcinoembryonic Antigen Market, by Laboratories, Value, 2015-2027 (US$ Mn)
FIG. 19 Global Carcinoembryonic Antigen Market, by Others, Value, 2015-2027 (US$ Mn)
FIG. 20 U.S. Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 21 Rest of North America Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 22 U.K. Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 23 Germany Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 24 France Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 25 Rest of Europe Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 26 Japan Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 27 China Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 28 India Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 29 Rest of Asia Pacific Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
FIG. 30 Middle East & Africa Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
Latin America Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Carcinoembryonic Antigen Market
TABLE 2 Global Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 3 Global Carcinoembryonic Antigen Market, by End-user, 2015-2027 (US$ Mn)
TABLE 4 Global Carcinoembryonic Antigen Market, by Geography, 2015-2027 (US$ Mn)
TABLE 5 North America Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 6 North America Carcinoembryonic Antigen Market, by Country, 2015-2027 (US$ Mn)
TABLE 7 Europe Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 8 Europe Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)
TABLE 9 Asia Pacific Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 10 Asia Pacific Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)
TABLE 11 Latin America Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 12 Latin America Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)
TABLE 13 Middle East Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 14 Middle East Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)
TABLE 15 Africa Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)
TABLE 16 Africa Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)
TABLE 17 F. Hoffmann-La Roche Ltd : Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 18 Abbott Diagnostics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 19 GenWay Biotech Inc.,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 20 Quest Diagnostics,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Creative Diagnostics,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Correlogic Systems, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 23 , Omega Diagnostics Group PLC: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 24 RayBiotech, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 25 Boster Biological Technology : Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
Qiagen N.V.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments